| N-[4-(2-Cyanoethyl)cyclohexyl]-N-cyclopropyl-4-[(2S)-1,1,1-trifluoro-2-hydroxypropan-2-yl]benzamide | IC50 | 1.4 [1] |
| (6S)-3-[(1S)-1-[4-(2,4-Difluorophenyl)phenyl]ethyl]-6-(4-fluorophenyl)-6-(2-hydroxyethyl)-1,3-oxazinan-2-one | IC50 | 2.5 [1] |
| N-Cyclopropyl-N-(4-pyridin-3-ylcyclohexyl)-4-[(2S)-1,1,1-trifluoro-2-hydroxypropan-2-yl]benzamide | IC50 | 3.0 [1] |
| Enoxolone | IC50 | 13.0 [1] |
| 2-(2-(3-Chloro-2-methylphenylsulfonamido)thiazol-4-yl)-N,N-diethylacetamide | IC50 | 52.0 [1] |
| N-Cyclopropyl-N-(4-phenylcyclohexyl)-4-[(2S)-1,1,1-trifluoro-2-hydroxypropan-2-yl]benzamide | IC50 | 9.8 [1] |
| (6R)-3-[(1S)-1-[4-(2,4-Difluorophenyl)phenyl]ethyl]-6-(3-hydroxypropyl)-6-phenyl-1,3-oxazinan-2-one | IC50 | 0.72 [1] |
| (R)-3-((S)-1-(4'-Fluorobiphenyl-4-yl)ethyl)-6-(3-hydroxypropyl)-6-phenyl-1,3-oxazinan-2-one | IC50 | 0.6 [1] |
| (S)-3-((S)-1-(4'-Fluorobiphenyl-4-yl)ethyl)-6-(4-fluorophenyl)-6-(2-hydroxyethyl)-1,3-oxazinan-2-one | IC50 | 1.5 [1] |
| 3-[(6R)-3-[(1S)-1-[4-(2,4-Difluorophenyl)phenyl]ethyl]-6-(4-fluorophenyl)-2-oxo-1,3-oxazinan-6-yl]propanamide | IC50 | 5.0 [1] |
| N-[3-[(6R)-3-[(1S)-1-[4-(2,4-Difluorophenyl)phenyl]ethyl]-6-(4-fluorophenyl)-2-oxo-1,3-oxazinan-6-yl]propyl]methanesulfonamide | IC50 | 3.7 [1] |
| {(3s)-1-[5-(Cyclohexylcarbamoyl)-6-(Propylsulfanyl)pyridin-2-Yl]piperidin-3-Yl}acetic Acid | IC50 | 2.0 [1] |
| 1-[[(3R)-3-Methyl-4-[4-[(2S)-1,1,1-trifluoro-2-hydroxypropan-2-yl]phenyl]sulfonylpiperazin-1-yl]methyl]cyclopropane-1-carboxamide | IC50 | 0.7 [1], 0.83 [2], 1.2 [3], 7.3 [4], 14.0 [5] |
| 1-[[(3R)-3-Methyl-4-[4-[(2S)-1,1,1-trifluoro-2-hydroxypropan-2-yl]phenyl]sulfonylpiperazin-1-yl]methyl]cyclopropane-1-carboxamide | Ki | 1.1 [1], 2.7 [2] |
| N-Cyclopropyl-N-(4-cyclopropyl-4-hydroxycyclohexyl)-4-[(2S)-1,1,1-trifluoro-2-hydroxypropan-2-yl]benzamide | IC50 | 52.0 [1] |
| (6S)-3-[(1S)-1-(4-Bromophenyl)ethyl]-6-(4-fluorophenyl)-6-(2-hydroxy-2-methylpropyl)-1,3-oxazinan-2-one | IC50 | 1.9 [1] |
| Amg-221 | IC50 | 7.0 [1], 10.1 [2], 10000.0 [3] |
| Amg-221 | Ki | 12.8 [1] |
| N-[4-(4-Cyanophenyl)cyclohexyl]-N-cyclopropyl-4-[(2S)-1,1,1-trifluoro-2-hydroxypropan-2-yl]benzamide | IC50 | 3.4 [1] |
| 9-[[2-Methyl-2-[4-[5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]propanoyl]amino]bicyclo[3.3.1]nonane-3-carboxamide | IC50 | 88.0 [1] |
| N-[4-(2-Cyano-2-methylpropyl)cyclohexyl]-N-cyclopropyl-4-[(2S)-1,1,1-trifluoro-2-hydroxypropan-2-yl]benzamide | IC50 | 2.0 [1] |
| N-Cyclopropyl-N-(4-hydroxy-4-phenylcyclohexyl)-4-[(2S)-1,1,1-trifluoro-2-hydroxypropan-2-yl]benzamide | IC50 | 150.0 [1] |
| N-(4-Cyano-4-pyridin-2-ylcyclohexyl)-N-cyclopropyl-4-[(2R)-1,1,1-trifluoro-2-hydroxypropan-2-yl]benzamide | IC50 | 39.0 [1] |
| N-[4-(3-Amino-3-oxopropyl)cyclohexyl]-N-cyclopropyl-4-[(2R)-1,1,1-trifluoro-2-hydroxypropan-2-yl]benzamide | IC50 | 17.0 [1] |
| N-[4-Cyano-4-(4-fluorophenyl)cyclohexyl]-N-cyclopropyl-4-[(2R)-1,1,1-trifluoro-2-hydroxypropan-2-yl]benzamide | IC50 | 48.0 [1] |
| N-[4-(Cyanomethyl)cyclohexyl]-N-cyclopropyl-4-[(2R)-1,1,1-trifluoro-2-hydroxypropan-2-yl]benzamide | IC50 | 16.0 [1] |
| Carbenoxolone | IC50 | 83.0 [1], 330.0 [2], 500.0 [3] |
| 3-(1-Adamantyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | IC50 | 7.5 [1], 7.8 [2], 8.0 [3] |
| N-Adamantan-2-Yl-1-Ethyl-D-Prolinamide | IC50 | 4.0 [1], 4.1 [2], 4.15 [3], 90.0 [4] |
| N-Adamantan-2-Yl-1-Ethyl-D-Prolinamide | Ki | 1.4 [1] |
| N-[(E)-5-Hydroxy-2-adamantyl]-2-{4-[5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl}acetamide | IC50 | 130.0 [1], 15000.0 [2] |
| N-[(E)-5-Hydroxy-2-adamantyl]-2-{4-[5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl}acetamide | Ki | 8.0 [1], 67.0 [2] |
| (6S)-3-[3-(2,4-Difluorophenyl)phenyl]-6-(2-hydroxyethyl)-6-phenyl-1,3-oxazinan-2-one | IC50 | 0.77 [1], 11.97 [2] |
| (6S)-3-[(1S)-1-[4-(4-Fluorophenyl)phenyl]ethyl]-6-(2-hydroxy-2-methylpropyl)-6-phenyl-1,3-oxazinan-2-one | IC50 | 1.08 [1], 19.54 [2] |
| (S)-3-((S)-1-(4-Bromophenyl)ethyl)-6-(2-hydroxy-2-methylpropyl)-6-phenyl-1,3-oxazinan-2-one | IC50 | 0.79 [1], 8.94 [2] |
| (6S)-3-[6-(4-Fluorophenyl)pyridin-2-yl]-6-(2-hydroxyethyl)-6-phenyl-1,3-oxazinan-2-one | IC50 | 1.44 [1], 15.24 [2] |
| (6S)-3-[(1S)-1-[4-(Difluoromethoxy)phenyl]ethyl]-6-(4-fluorophenyl)-6-(2-hydroxyethyl)-1,3-oxazinan-2-one | IC50 | 1.3 [1], 8.94 [2] |
| 3-[6-(2,4-Difluorophenyl)pyridin-2-yl]-6-(2-fluorophenyl)-6-(2-hydroxyethyl)-1,3-oxazinan-2-one | IC50 | 1.8 [1], 14.16 [2] |
| (6S)-3-[(1S)-1-[4-(2,4-Difluorophenyl)phenyl]ethyl]-6-(4-fluorophenyl)-6-(2-hydroxy-2-methylpropyl)-1,3-oxazinan-2-one | IC50 | 1.48 [1], 37.58 [2] |
| 3-((R)-3-((S)-1-(4'-Fluorobiphenyl-4-yl)ethyl)-2-oxo-6-phenyl-1,3-oxazinan-6-yl)propanamide | IC50 | 0.55 [1], 13.4 [2] |
| Acetoxolone | IC50 | 800.0 [1], 3450.0 [2], 7100.0 [3], 7138.0 [4] |
| 3-(4-Fluorophenyl)-5-[4-[4-methyl-5-[2-(trifluoromethyl)phenyl]-1,2,4-triazol-3-yl]-1-bicyclo[2.2.2]octanyl]-1,2,4-oxadiazole | IC50 | 2.0 [1], 2.2 [2], 2200.0 [3] |
| N-(2-Adamantyl)piperidine-1-carboxamide | IC50 | 16.0 [1], 16.1 [2], 32.0 [3], 873.0 [4] |
| (5s)-2-{[(1s)-1-(2-Fluorophenyl)ethyl]amino}-5-Methyl-5-(Trifluoromethyl)-1,3-Thiazol-4(5h)-One | IC50 | 33.0 [1], 10000.0 [2] |
| (5s)-2-{[(1s)-1-(2-Fluorophenyl)ethyl]amino}-5-Methyl-5-(Trifluoromethyl)-1,3-Thiazol-4(5h)-One | Ki | 22.0 [1] |
| [4-[Cyclopropyl-[4-[(2S)-1,1,1-trifluoro-2-hydroxypropan-2-yl]benzoyl]amino]-1-(4-fluorophenyl)cyclohexyl]methyl carbamate | IC50 | 0.5 [1], 12.0 [2], 15.0 [3], 34.0 [4] |
| (2R)-1-[(4-Tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine | IC50 | 3.0 [1], 57.0 [2] |
| 9-[[2-(4-Chlorophenoxy)-2-methylpropanoyl]amino]bicyclo[3.3.1]nonane-3-carboxamide | IC50 | 5.0 [1], 5.01 [2], 8.0 [3], 21.88 [4] |
| (6R)-6-(2-Aminoethyl)-3-[(1S)-1-[4-(2,4-difluorophenyl)phenyl]ethyl]-6-(4-fluorophenyl)-1,3-oxazinan-2-one | IC50 | 2.7 [1], 66.0 [2], 66.5 [3] |
| 6-[4-(4-Cyanophenyl)piperazin-1-yl]-N-(5-hydroxy-2-adamantyl)pyridine-2-carboxamide | IC50 | 2.8 [1], 6.7 [2] |
| 4-[[1-[4-[5-(Trifluoromethyl)pyridin-2-yl]piperazin-1-yl]cyclopropanecarbonyl]amino]adamantane-1-carboxylic acid | IC50 | 45.0 [1], 1900.0 [2] |
| 4-[[1-[4-[5-(Trifluoromethyl)pyridin-2-yl]piperazin-1-yl]cyclopropanecarbonyl]amino]adamantane-1-carboxylic acid | Ki | 7.0 [1], 250.0 [2] |
| N-[(E)-5-Fluoro-2-adamantyl]-2-{4-[5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl}acetamide | IC50 | 450.0 [1], 550.0 [2] |
| N-[(E)-5-Fluoro-2-adamantyl]-2-{4-[5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl}acetamide | Ki | 26.0 [1], 32.0 [2] |
| N-(5-Hydroxy-2-adamantyl)-1-piperidin-1-ylcyclopropane-1-carboxamide | IC50 | 7.0 [1], 390.0 [2] |
| N-(5-Hydroxy-2-adamantyl)-1-piperidin-1-ylcyclopropane-1-carboxamide | Ki | 2.0 [1], 6.0 [2] |
| 4-[[1-[4-[5-(Trifluoromethyl)pyridin-2-yl]piperazin-1-yl]cyclopropanecarbonyl]amino]adamantane-1-carboxamide | IC50 | 22.0 [1], 490.0 [2] |
| 4-[[1-[4-[5-(Trifluoromethyl)pyridin-2-yl]piperazin-1-yl]cyclopropanecarbonyl]amino]adamantane-1-carboxamide | Ki | 8.0 [1], 13.0 [2] |
| (S)-N-(trans-4-Fluorocyclohexyl)-4-(1,1,1-trifluoro-2-hydroxypropan-2-yl)-N-cyclopropylbenzamide | IC50 | 4.1 [1], 6.6 [2], 36.0 [3], 140.0 [4] |
| 9-[4-[(5-Cyanopyridin-2-yl)oxymethyl]-3,3-dimethyl-2-oxopyrrolidin-1-yl]bicyclo[3.3.1]nonane-3-carboxamide | IC50 | 5.0 [1], 39.0 [2], 510.0 [3] |
| 9-[4-[(5-Cyanopyridin-2-yl)oxymethyl]-3,3-dimethyl-2-oxopyrrolidin-1-yl]bicyclo[3.3.1]nonane-3-carboxamide | Ki | 29.0 [1] |
| N-[4-(3-Amino-3-oxopropyl)-4-phenylcyclohexyl]-N-cyclopropyl-4-[(2S)-1,1,1-trifluoro-2-hydroxypropan-2-yl]benzamide | IC50 | 0.8 [1], 3.9 [2], 17.0 [3], 37.0 [4] |
| N-(5-Fluoro-7-hydroxy-2-adamantyl)-2-[4-[5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]propanamide | IC50 | 120.0 [1], 3400.0 [2] |
| N-(5-Fluoro-7-hydroxy-2-adamantyl)-2-[4-[5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]propanamide | Ki | 12.0 [1], 46.0 [2] |
| (6S)-6-(2-Hydroxy-2-methylpropyl)-3-[(1S)-1-[4-(1-methyl-6-oxopyridin-3-yl)phenyl]ethyl]-6-phenyl-1,3-oxazinan-2-one | IC50 | 1.6 [1], 1.67 [2], 3.3 [3], 6.44 [4] |
| (6S)-6-(2-Hydroxy-2-methylpropyl)-3-[(1S)-1-[4-(1-methyl-2-oxopyridin-4-yl)phenyl]ethyl]-6-phenyl-1,3-oxazinan-2-one | IC50 | 1.62 [1], 1.7 [2], 4.3 [3], 5.54 [4] |
| [4-[Cyclopropyl-[4-[(2S)-1,1,1-trifluoro-2-hydroxypropan-2-yl]benzoyl]amino]-1-(5-fluoropyridin-2-yl)cyclohexyl]methyl carbamate | IC50 | 2.4 [1], 30.0 [2], 31.0 [3], 93.0 [4] |
| N-[4-(3-Amino-3-oxopropyl)-4-(4-fluorophenyl)cyclohexyl]-N-cyclopropyl-4-[(2S)-1,1,1-trifluoro-2-hydroxypropan-2-yl]benzamide | IC50 | 1.8 [1], 12.0 [2], 24.0 [3], 55.0 [4] |
| [4-[Cyclopropyl-[4-[(2S)-1,1,1-trifluoro-2-hydroxypropan-2-yl]benzoyl]amino]-1-phenylcyclohexyl]methyl carbamate | IC50 | 1.0 [1], 4.6 [2], 8.8 [3], 20.0 [4] |
| N-Cyclopropyl-N-[4-(2-hydroxyethyl)-4-phenylcyclohexyl]-4-[(2S)-1,1,1-trifluoro-2-hydroxypropan-2-yl]benzamide | IC50 | 1.9 [1], 12.0 [2], 15.0 [3], 35.0 [4] |
| N-[4-(Acetamidomethyl)-4-phenylcyclohexyl]-N-cyclopropyl-4-[(2S)-1,1,1-trifluoro-2-hydroxypropan-2-yl]benzamide | IC50 | 2.2 [1], 6.7 [2], 17.0 [3], 129.0 [4] |
| [4-[Cyclopropyl-[4-[(2S)-1,1,1-trifluoro-2-hydroxypropan-2-yl]benzoyl]amino]-1-(1,3-thiazol-4-yl)cyclohexyl]methyl carbamate | IC50 | 1.8 [1], 16.0 [2], 18.0 [3], 63.0 [4] |
| [4-[Cyclopropyl-[4-[(2S)-1,1,1-trifluoro-2-hydroxypropan-2-yl]benzoyl]amino]-1-(2-fluorophenyl)cyclohexyl]methyl carbamate | IC50 | 0.6 [1], 5.7 [2], 14.0 [3], 135.0 [4] |
| [4-[Cyclopropyl-[4-[(2S)-1,1,1-trifluoro-2-hydroxypropan-2-yl]benzoyl]amino]-1-pyridin-2-ylcyclohexyl]methyl carbamate | IC50 | 3.5 [1], 19.0 [2], 25.0 [3], 74.0 [4] |
| N-Cyclopropyl-N-[4-(methanesulfonamidomethyl)-4-phenylcyclohexyl]-4-[(2S)-1,1,1-trifluoro-2-hydroxypropan-2-yl]benzamide | IC50 | 1.7 [1], 20.0 [2], 86.0 [3], 259.0 [4] |
| N-[4-(3-Amino-3-oxopropyl)-4-(2-fluorophenyl)cyclohexyl]-N-cyclopropyl-4-[(2S)-1,1,1-trifluoro-2-hydroxypropan-2-yl]benzamide | IC50 | 1.3 [1], 7.0 [2], 36.0 [3], 109.0 [4] |
| (6R)-6-(3-Hydroxypropyl)-3-[(1S)-1-[4-(1-methyl-6-oxopyridin-3-yl)phenyl]ethyl]-6-phenyl-1,3-oxazinan-2-one | IC50 | 1.4 [1], 1.44 [2], 3.42 [3], 5.7 [4] |
| Glycyrrhizic acid | IC50 | 6.0 [1], 10.0 [2], 18.6 [3] |
| 3-Chloro-2-methyl-N-(4-(2-(4-methylpiperazin-1-yl)-2-oxoethyl)thiazol-2-yl)benzenesulfonamide | IC50 | 3341.0 [1], 10000.0 [2] |
| 3-(1-Adamantyl)-4-methyl-5-phenyl-1,2,4-triazole | IC50 | 37.0 [1], 109.0 [2] |
| 4-Methyl-3-(4-pentyl-1-bicyclo[2.2.2]octanyl)-5-[2-(trifluoromethyl)phenyl]-1,2,4-triazole | IC50 | 1.8 [1], 2.0 [2] |
| 3-(1-(4-Chlorophenyl)cyclobutyl)-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[4,3-a]azocine | IC50 | 1.0 [1], 1.3 [2] |
| 2-(Phenylsulfonyl)-1-(4-(trifluoromethyl)phenyl)ethanone | IC50 | 187.0 [1], 190.0 [2] |
| N-[(E)-5-Hydroxy-2-adamantyl]-2-{4-[5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl}propionamide | IC50 | 5.0 [1], 29.0 [2] |
| N-[(E)-5-Hydroxy-2-adamantyl]-2-{4-[5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl}propionamide | Ki | 5.0 [1] |
| 1-(3-Hydroxyazetidin-1-yl)-2-(6-hydroxy-2-phenyl-2-adamantyl)ethanone | IC50 | 10.0 [1], 37.3 [2] |
| 1-(3-Hydroxyazetidin-1-yl)-2-(6-hydroxy-2-phenyl-2-adamantyl)ethanone | Ki | 3.8 [1] |
| 3-Biphenyl-4-yl-5-[1-(4-chloro-phenyl)-cyclobutyl]-4-methyl-4H-[1,2,4]triazole | IC50 | 11.0 [1] |
| 2-(2-Chloro-4-fluorophenoxy)-2-methyl-N-[5-(2H-tetrazol-5-yl)-2-adamantyl]propanamide | IC50 | 10.96 [1], 11.0 [2], 54.0 [3] |
| 4-[[2-(4-Chlorophenoxy)-2-methylpropanoyl]amino]adamantane-1-carboxylic acid | IC50 | 21.88 [1], 22.0 [2], 220.0 [3] |
| E-4-[(2-Methyl-2-phenoxypropanoyl)amino]adamantane-1-carboxamide | IC50 | 5.0 [1], 5.01 [2], 24.0 [3] |
| 4-[[2-(4-Methoxyphenoxy)-2-methylpropanoyl]amino]adamantane-1-carboxamide | IC50 | 6.0 [1], 6.03 [2], 21.0 [3] |
| 4-[[2-(4-Chlorophenoxy)-2-methylpropanoyl]amino]adamantane-1-carboxamide | IC50 | 6.0 [1], 6.03 [2], 22.0 [3] |
| 4-[[2-(2-Chlorophenoxy)-2-methylpropanoyl]amino]adamantane-1-carboxylic acid | IC50 | 7.94 [1], 8.0 [2], 59.0 [3] |
| 4-(2-(4-Chlorophenoxy)-2-methylpropanamido)bicyclo[2.2.2]octane-1-carboxamide | IC50 | 12.88 [1], 13.0 [2], 450.0 [3] |
| 1-Naphthalen-2-ylsulfonyl-4-[3-(trifluoromethyl)pyridin-2-yl]piperazine | IC50 | 11.0 [1], 13.0 [2], 547.0 [3] |
| 1-(Phenylsulfonyl)-4-[3-(trifluoromethyl)pyridin-2-yl]piperazine | IC50 | 45.0 [1], 724.0 [2] |
| 1-Naphthalen-1-ylsulfonyl-4-[3-(trifluoromethyl)pyridin-2-yl]piperazine | IC50 | 13.0 [1], 329.0 [2] |
| 9-[[2-(4-Chlorophenoxy)-2-methylpropanoyl]amino]-3-oxabicyclo[3.3.1]nonane-7-carboxamide | IC50 | 25.0 [1], 25.12 [2], 2400.0 [3] |
| 2-(4-Chlorophenoxy)-N-(1-hydroxy-2-oxatricyclo[3.3.1.13,7]decan-6-yl)-2-methylpropanamide | IC50 | 15.0 [1], 15.14 [2], 199.0 [3] |